Recommended for adenoma that grow despite surgery, RT, and optimized medical therapyMost common regimens: standard dose for 6 cycles if monotherapy, lower dose if given with RTRechallenge after progression is typically less effectiveUnclear whether MGMT status is useful in predicting responseLonger duration of therapy may sustain response. The gene discussed is MGMT; the disease is adenoma.